| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/07/2014 | US8623384 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of acute myelogenous leukemia |
| 01/07/2014 | US8623378 Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof |
| 01/07/2014 | US8623373 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 01/07/2014 | US8623357 Therapeutic antibodies |
| 01/07/2014 | US8623349 Systems, methods and microrganisms for antibody production with type III secretion system |
| 01/07/2014 | US8623343 Highly cationic copolymers based on quaternized nitrogen-containing monomers |
| 01/07/2014 | US8623336 Transparent xyloglucan/chitosan gel and a process for the preparation thereof |
| 01/07/2014 | US8623323 Thickened beverages for dysphagia |
| 01/07/2014 | CA2763775C Bisphosphonic acids for the treatment and prevention of osteoporosis |
| 01/07/2014 | CA2733212C Arginine silicate inositol complex and use thereof |
| 01/07/2014 | CA2636618C Oral s-adenosylmethionine compositions |
| 01/07/2014 | CA2629988C Pharmaceutical composition for the treatment of acute disorders |
| 01/07/2014 | CA2560922C Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions |
| 01/07/2014 | CA2546675C Pharmaceutical formulations for the sustained release of one or more active principles and applications thereof, such as therapeutic applications |
| 01/07/2014 | CA2512657C Protein complex using immunoglobulin fragment and method for the preparation thereof |
| 01/07/2014 | CA2492472C Use of urease for inhibiting cancer cell growth |
| 01/07/2014 | CA2464472C Antibody targeting compounds |
| 01/07/2014 | CA2453967C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/07/2014 | CA2427896C Carrier vectors through an epithelium with tight junctions |
| 01/07/2014 | CA2319404C Recombinant lipidated psaa protein, methods of preparation and use |
| 01/03/2014 | WO2014005021A1 Racecadotril liquid compositions |
| 01/03/2014 | WO2014004895A1 Stable formulations for parenteral injection of small molecule drugs |
| 01/03/2014 | WO2014004639A1 Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use |
| 01/03/2014 | WO2014004549A2 Anti-mesothelin binding proteins |
| 01/03/2014 | WO2014004512A1 Bioerodable poly(etheresteramides) and medical article uses |
| 01/03/2014 | WO2014003874A1 Method to enhance swallowing safety and appeal of beverages for treating dysphagia based on rheological and sensory parameters |
| 01/03/2014 | WO2014003850A2 Methods for treatment of ocular diseases |
| 01/03/2014 | WO2014003740A1 Weight loss and satiation composition |
| 01/03/2014 | WO2014003199A1 Liquid preparations of amines and organic acids stabilized by salts |
| 01/03/2014 | WO2014003116A1 Nutritional composition |
| 01/03/2014 | WO2014002851A1 Solid pharmaceutical tablet and method for producing same |
| 01/03/2014 | WO2014002553A1 Aripiprazole oral pharmaceutical preparation |
| 01/03/2014 | WO2014002108A1 A core-shell nanostructure on the basis of proteins with corresponding therapeutic agents |
| 01/03/2014 | WO2014002039A1 Amphetamine prodrugs |
| 01/03/2014 | WO2014002015A1 Pharmaceutical composition comprising dutasteride |
| 01/03/2014 | WO2014001967A1 Anti-tofacitinib antibodies and uses thereof for drug monitoring |
| 01/03/2014 | WO2014001905A1 Biodegradable drug delivery for hydrophobic compositions |
| 01/03/2014 | WO2014001904A1 Biodegradable drug delivery for hydrophobic compositions |
| 01/03/2014 | WO2014001749A1 Formulation comprising crh and alpha - 2 - immunoglobulin |
| 01/03/2014 | WO2014001668A1 Novel surfactant-free self-reversible reverse latex, and use of same as a thickening agent in a cosmetic composition |
| 01/03/2014 | WO2014001653A1 Monopolymer multifunctional sequenced cast polyurethane matrix and production method |
| 01/03/2014 | WO2014001509A1 Functionalized liposomes useful for the delivery of bioactive compounds |
| 01/03/2014 | WO2014000857A1 Liposomes active in-vivo on neurodegenerative diseases (in particular alzheimer's disease) |
| 01/03/2014 | WO2013173789A3 Antisense oligonucleotide compositions |
| 01/03/2014 | CA2877968A1 Methods and compositions for natural killer cells |
| 01/03/2014 | CA2877909A1 Stable formulations for parenteral injection of small molecule drugs |
| 01/03/2014 | CA2877765A1 Liposomes active in-vivo on neurodegenerative diseases (in particular alzheimer's disease) |
| 01/03/2014 | CA2877724A1 Racecadotril liquid compositions |
| 01/03/2014 | CA2877619A1 Liquid preparations of amines and organic acids stabilized by salts |
| 01/03/2014 | CA2877562A1 Formulation comprising crh and alpha-2-immunoglobulin |
| 01/03/2014 | CA2877130A1 Temperature stable vaccine formulations |
| 01/03/2014 | CA2803566A1 Syringe |
| 01/02/2014 | US20140005419 Method for Preparing a Polymer Conjugate |
| 01/02/2014 | US20140005379 Nanoparticle delivery system and components thereof |
| 01/02/2014 | US20140005280 Carboxymethyl starch and chitosan polyelectrolyte complexes |
| 01/02/2014 | US20140005278 Linear polyester and semi-linear glycidol polymer systems: formulation and synthesis of novel monomers and macromolecular structures |
| 01/02/2014 | US20140005277 Aqueous ophthalmic composition |
| 01/02/2014 | US20140005274 Aqueous ophthalmic composition |
| 01/02/2014 | US20140005269 Polymeric matrix of polymer-lipid nanoparticles as a pharmaceutical dosage form |
| 01/02/2014 | US20140005262 Racecadotril lipid compostions |
| 01/02/2014 | US20140005261 Racecadotril liquid compositions |
| 01/02/2014 | US20140005258 Delivery of Therapeutic Agents Using Oligonucleotide-Modified Nanoparticles as Carriers |
| 01/02/2014 | US20140005242 Allantoin-Containing Skin Cream |
| 01/02/2014 | US20140005199 Implant for the controlled release of pharmaceutically active agents |
| 01/02/2014 | US20140005171 Ophthalmic Ointment Composition Comprising a Drug, an Ointment Base and a Solubilizing/Dispersing Agent |
| 01/02/2014 | US20140005153 Off-Note Masking |
| 01/02/2014 | US20140005140 Composition, in aqueous medium, that comprises at least a hyaluronic acid and at least an hydrosoluble salt of sucrose octasulfate |
| 01/02/2014 | US20140005135 Stable formulations for parenteral injection of small molecule drugs |
| 01/02/2014 | US20140005115 Lipid conjugates in the treatment of bronchitis |
| 01/02/2014 | US20140005111 Injectable delivery system for heparan-binding growth factors |
| 01/02/2014 | US20140005106 Method for administering glp-1 molecules |
| 01/02/2014 | US20140005105 Plasma anti-diabetic nucb2 peptide (pladin) and uses thereof |
| 01/02/2014 | US20140004207 Analgesic Apatitic Calcium-Phosphate Cement |
| 01/02/2014 | US20140004204 Biocompatible polyacrylate compositions and methods of use |
| 01/02/2014 | US20140004199 Drug carrier for tumor-targeted therapy, its preparation method and its use |
| 01/02/2014 | US20140004197 O/w-emulsions comprising semifluorinated alkanes |
| 01/02/2014 | US20140004190 Solid Dosage Forms of Bendamustine |
| 01/02/2014 | US20140004175 Angiopoietin derived peptides |
| 01/02/2014 | US20140004095 Albumin fusion proteins |
| 01/02/2014 | US20140004078 Immunoconjugates with an Intracellularly-Cleavable Linkage |
| 01/02/2014 | US20140004074 Pharmaceutical Formulations of Biodegradable Biocompatible Camptothecin-Polymer Conjugates |
| 01/02/2014 | US20140004042 Targeted delivery to human diseases and disorders |
| 01/02/2014 | US20140004040 Methods and compositions for targeting sites of neovascular growth |
| 01/02/2014 | DE102012211121A1 Granuläre, funktionalisierte Kieselsäure, Verfahren zu deren Herstellung und deren Verwendung Granular functionalized silica, processes for their preparation and their use |
| 01/02/2014 | CA2877083A1 Biodegradable drug delivery for hydrophobic compositions |
| 01/01/2014 | EP2679584A1 Clathrate complex of cyclodextrin or arabinogalactan with 9-phenyl-sym-octahydroselenoxanthene |
| 01/01/2014 | EP2679251A1 Adhesive compositions for medical use: single additive as both the thickening agent and the accelerator |
| 01/01/2014 | EP2679245A2 Formulations which stabilize and inhibit precipitation of immunogenic compositions |
| 01/01/2014 | EP2679244A2 Formulations which stabilize and inhibit precipitation of immunogenic compositions |
| 01/01/2014 | EP2679243A1 Co-precipitate of one or more stilbene polyphenols and their derivatives in lamellar anionic solids, it's applications and related preparation method |
| 01/01/2014 | EP2679230A1 Pharmaceutical formulation comprising compounds of the jasmonate family |
| 01/01/2014 | EP2679227A1 Nanoparticle containing prostaglandin i2 derivative |
| 01/01/2014 | EP2679222A1 Use of oligomers of lactic acid in the treatment of gynaecological infections |
| 01/01/2014 | EP2679218A1 Moisturising Composition |
| 01/01/2014 | EP2679217A1 Non-protein stabilized clostridial toxin pharmaceutical compositions |
| 01/01/2014 | EP2678693A2 Paper support and method of recovering biological material therefrom |
| 01/01/2014 | EP2678350A1 A cyclic peptide and conjugate thereof for binding to keratinocytes |
| 01/01/2014 | EP2678326A1 Monomers and polymers for functional polycarbonates and poly (ester-carbonates) and peg-co-polycarbonate hydrogels |
| 01/01/2014 | EP2678042A2 Amphiphilic dendron-coils, micelles thereof and uses |
| 01/01/2014 | EP2678041A2 Materials for modulating biological responses and methods of making |